Brokerages Set Ardent Health Partners, LLC (NYSE:ARDT) Price Target at $20.75

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has been given a consensus recommendation of "Buy" by the thirteen brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $20.75.

Several equities analysts have weighed in on the company. Guggenheim raised their price target on Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Mizuho dropped their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Morgan Stanley dropped their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Stephens reaffirmed an "overweight" rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health Partners in a research report on Thursday.

Ardent Health Partners Price Performance

NYSE ARDT traded up $0.17 during mid-day trading on Wednesday, hitting $15.40. The stock had a trading volume of 503,048 shares, compared to its average volume of 397,811. Ardent Health Partners has a 52-week low of $11.31 and a 52-week high of $20.72. The company has a market cap of $2.20 billion and a price-to-earnings ratio of 9.45. The company has a 50 day simple moving average of $13.13 and a 200 day simple moving average of $14.86. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.50 billion. Equities analysts forecast that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health Partners

A number of institutional investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. grew its position in Ardent Health Partners by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock valued at $10,558,000 after acquiring an additional 724,841 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Ardent Health Partners during the first quarter worth about $469,000. PharVision Advisers LLC acquired a new position in shares of Ardent Health Partners during the first quarter worth about $188,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Ardent Health Partners by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock worth $194,000 after purchasing an additional 7,182 shares in the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of Ardent Health Partners during the first quarter worth about $2,886,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.